Pattrick, M.
Sarrigiannis, P. G.
Kruger, S.
Davies, B.
Hoggard, N.
Irani, S. R.
Unwin, Z.
Zis, P.
Blackburn, D. J.
Hadjivassiliou, Marios
Article History
Received: 26 May 2020
Revised: 15 June 2020
Accepted: 20 August 2020
First Online: 30 August 2020
Compliance with ethical standards
:
: The authors have no conflicts of interest to disclose.
: This article summarizes observational case series of 3 patients with DPPX-ARA being managed at the Sheffield Ataxia Centre (SAC), Sheffield UK. The South Yorkshire Research Ethics Committee has confirmed that no ethical approval is indicated given that immunosuppression is a recognized treatment for DPPX-ARA and that all investigations/interventions were clinically indicated and did not form part of a research study.
: The corresponding author had full access to all the data and takes responsibility for the integrity of the data and the accuracy of the data analysis.